Want to contact a Washington, DC Baxter Heparin attorney? ...Get a free case evaluation from one of our Washington, DC Baxter Heparin attorneys now.
Home : Unsafe Drugs : Baxter Heparin : MSN Newsfeeds
Baxter Heparin - MSN Newsfeeds
- Palladium-Item - Overdosing babies on heparin and giving laboring mother too much medicine in her epidural paralyzing her? I'm not saying they goofed but my opinion of Methodist has deteriorated since those problems as well as some others. I don't care for any of the ...
- Chicago Tribune - With rival blood-thinning drugmaker Baxter International Inc. reeling from a federal investigation into its manufacturing operations, the stock of APP Pharmaceuticals Inc. jumped more than 8 percent Tuesday after the company said it will meet the ...
- Globe and Mail - In November, Quaid and his wife, Kimberly, were horrified to discover that their children were accidentally given massive overdoses of the anti-coagulant heparin at Los Angeles's Cedars-Sinai Medical Center. “They're fantastic, really good. They ...
- Chicago Tribune - Shares of Schaumburg-based APP Pharmaceuticals Inc., the maker of the blood-thinning drug heparin, jumped nearly 8 percent today after the company said it will begin meeting customer demand in the wake of problems Baxter International Inc. is having ...
- Boston Globe - The lead author and peer reviewers of a government report raising the possibility of public health threats from industrial contamination throughout the Great Lakes region are charging that the report is being suppressed because of the questions it ...
-
CNBC - NEW YORK (Reuters) - Some major hospitals are switching from using a heparin blood thinner product made by Baxter International Inc
to one produced by its rival APP Pharmaceuticals Inc , the Wall Street Journal reported on Tuesday ... -
Boston Globe - NEW YORK (Reuters) - Some major hospitals are switching from using a heparin blood thinner product made by Baxter International Inc
to one produced by its rival APP Pharmaceuticals Inc , the Wall Street Journal reported on Tuesday ... - Washington Post - The Chinese facility that supplies the active ingredient of the widely used blood thinner heparin was never inspected by the Food and Drug Administration because the agency confused its name with another just like it, agency officials said yesterday ...
- Wall Street Journal - Marc Moreau, senior director of materials management at Fresenius, said, "We're no longer ordering Baxter heparin at this point. We are using just the APP product." Fresenius has 120,000 dialysis patients who get treatments three times a week, and is ...
- Wall Street Journal - Marc Moreau, senior director of materials management at Fresenius, said, "We're no longer ordering Baxter heparin at this point. We are using just the APP product." Fresenius has 120,000 dialysis patients who get treatments three times a week, and is ...
- Bloomberg - Feb. 18 (Bloomberg) -- U.S. regulators didn't inspect a Chinese plant that makes an ingredient tied to life-threatening side effects with the blood-thinner heparin because they mixed up records on that facility and another with a similar name ...
- CNBC - WASHINGTON - U.S. health officials evaluated the wrong factory when assessing the safety of a Chinese-made drug ingredient that may be a source of problems with a blood thinner, the Food and Drug Administration said Monday. Baxter International's ...
- Chicago Tribune - ... the FDA said it will do an on-site inspection this week of a plant in China that made a key ingredient in Deerfield -based Baxter's blood thinner, a popular drug that has been linked to potentially deadly allergic reactions in U.S. patients. Heparin ...
- International Herald Tribune - The agency also suggested that doctors give steroids or antihistamines with the Baxter heparin to help prevent allergic reactions. Erin Gardiner, a spokeswoman for Baxter, defended Scientific Protein, saying it had been making heparin for more than ...
- LabTechnologist.com - 14-Feb-2008 - Questions are hanging over the role of a Chinese manufacturing facility in the Baxter heparin scare after it has emerged that the US Food and Drug Administration (FDA) has never inspected the facility. Baxter has this week suspended the ...
- Medscape News - February 12, 2008 ( updated February 14, 2008 ) (Deerfield, Ill) - Baxter Healthcare Corporation has now temporarily stopped manufacturing multiple-dose vials of heparin because of reports of serious allergic reactions and hypotension in patients who ...
- Detroit News - John Jenkins, director of the Food and Drug Administration's office of new drugs, said doctors who had to continue to use Baxter heparin should use the lowest possible dose, infuse it slowly, monitor patients closely and consider administering ...
- ... family history of osteoporosis; those with inflammatory forms of arthritis such as rheumatoid arthritis and lupus; people who take cortisteroids, anticonvulsant medications or heparin; people who eat diets low in calcium; people with celiac ...
- Betrixaban is from a new class of medicines designed to prevent blood clots from forming with less risk of bleeding than with the older treatments warfarin and heparin. The new drugs could benefit about 2.2 million Americans who have atrial ...
- But the issue has risen again in recent years following high-profile scares involving Merck & Co's recalled painkiller Vioxx, Bayer's contaminated blood-thinner heparin and, most recently, concerns over GlaxoSmithKline 's diabetes drug Avandia.
Want to contact a Washington, DC Baxter Heparin attorney? ...Get a free case evaluation from one of our Washington, DC Baxter Heparin attorneys now.
Pages: 1 2 3 4 5 6 ... Next
